
596.82MUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US25056L1035
CUSIP
25056L103
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
3.17
Dividend Share
-
Dividend Yield
-
Earnings Share
-1.2
Wall Street Target Price
21.57
EPS Estimate Current Year
-1.33
EPS Estimate Next Year
-1.55
EPS Estimate Current Quarter
-0.3463
EPS Estimate Next Quarter
-0.3875
Most Recent Quarter
-
Revenue TTM
33,000
Gross Profit TTM
-61,118,000
EBITDA
-81,282,000
Profit Margin
0.00%
Return On Assets TTM
-23.88%
Return On Equity TTM
-36.87%
Revenue Per Share TTM
0.001
Qtly Revenue Growth YOY
0.00%
Diluted Eps TTM
-1.2
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
29402.82
Price Book MRQ
2.9548
Enterprise Value Revenue
17818
Enterprise Value EBITDA
0
965.00
0.00%128.26
0.00%390.94
-2.36%151.52
-2.31%925.70
-1.93%32.39
-1.88%318.32
-1.17%516.11
-1.04%917.00
-0.91%199.30
-0.11%